Thermo Fisher Scientific on Thursday forecast annual profit above Wall Street estimates, banking on improved demand for its products and services used in developing therapies, sending its shares up 6.

FusionLayer Inc. announced FusionLayer Xverse, a next-generation solution designed to transform security and infrastructure service deployment at the network edge. Xverse combines seamless, secure ...

Ataccama is a data quality company that helps organisations organise, understand and improve their data. The company recently ...

Shares of Thermo Fisher Scientific Inc. TMO slid 1.48% to $597.75 Friday, on what proved to be an all-around dismal trading ...

Stifel Nicolaus analyst Daniel Arias maintained a Buy rating on Thermo Fisher (TMO – Research Report) today and set a price target of $665.00.

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $654.0, with a high estimate of $680.00 and a low estimate of $605.00. Experiencing a 1.36% ...

Citi analyst Patrick B Donnelly maintained a Hold rating on Thermo Fisher (TMO – Research Report) yesterday and set a price target of ...

Shares of Thermo Fisher Scientific jumped Thursday after the company's fourth-quarter results topped estimates, as sales increased across all four of its divisions.

Thermo Fisher Scientific posted higher profit and revenue in the fourth quarter, and expressed confidence for the year ahead. The Waltham, Mass., maker of microscopes and other life-sciences and ...

Life sciences company Thermo Fisher (NYSE:TMO) reported Q4 CY2024 results , with sales up 4.7% year on year to $11.4 billion.

Thermo Fisher Scientific Inc. (NYSE:TMO) reported an earnings per share (EPS) of $6.10, beating the estimated $5.94. The ...